Skip to main content

Table 2 Cross-mapping of HRQoL concepts and themes identified from patient interviews with the AE-QoL questionnaire

From: Letting the patients speak: an in-depth, qualitative research-based investigation of factors relevant to health-related quality of life in real-world patients with hereditary angioedema using subcutaneous C1 inhibitor replacement therapy

Theme

Concept

AE-QoL coverage (AE-QoL item #)

Yes

Partiallya

No

HRQoL-related concepts

 HAE symptoms

No or nearly no attacks

  

X

 Change in impact of triggers

Stress/anxiety no longer a trigger

  

X

Sports no longer/less of a trigger

 

2

 

 Emotional

Less anxiety/worry caused by HAE

13, 14

  

Disease no longer limiting

12

  

Less depression/sadness caused by HAE

10

  

Less embarrassed/self-conscious

3, 16

  

 Work life/school

Less sick leave

1

  

Less missed school

 

1

 

Improved mental work capacity

 

1

 

Improved physical work capacity

1

  

 Social life/leisure

More able to travel

 

3

 

More keeping/less canceling social plans

 

3, 4

 

Spending more time with family/friends

 

3, 4

 

Ashamed of going out in public

4, 15

  

 Partner/family

Improved relationship with children

 

2, 4

 

Spouse/family needs to help less with administering medications

  

X

 Day-to-day activities

Improvement in day-to-day tasks

 

2

 

 Cognition

Improved general cognition

 

9

 

 Sleep/energy

Improved energy/less fatigue

 

8

 

Less trouble falling asleep

6

  

Less waking at night due to attacks

7

  

 Medical care

Less ER/hospital visits

  

X

Less routine HCP visits

  

X

No reliance on HCP to administer

  

X

 Sports/exercise

Improvement starting/resuming sports

 

2, 3

 

 Diet/appetite

Appetite is unaffected by abdominal attacks

 

5, 11

 

Treatment-specific concepts

 Experience with HAE treatments

Struggle to find a vein

  

X

Androgen side effects

  

X

 C1INH(SC) pros

Would recommend C1INH(SC)

  

X

Self-administration/independence

  

X

Prefer non-IV administration method

  

X

Able to administer in public/on-the-go

  

X

 Experience with C1INH(SC)

Ease of administration

  

X

Easy to remember to take

  

X

Confidence in use

  

X

Easy to learn to inject

  

X

 Long-term use

No concerns about long-term use

17

  
  1. Further detail on the cross-mapping between the AE-QoL questionnaire and patient interviews can be found in Additional file 2: Table S2
  2. AE-QoL Angioedema Quality of Life, C1INH(IV) intravenous C1 esterase inhibitor, ER emergency room, GERD gastroesophageal reflux disease, HAE hereditary angioedema
  3. a“Partially” indicates that AE-QoL items covering these topics were much more general/non-specific